Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2025-12-25 @ 2:29 PM
NCT ID: NCT03174366
Description: None
Frequency Threshold: 0
Time Frame: 1 year
Study: NCT03174366
Study Brief: Investigating the Use of Prolia (Denosumab) in the Treatment of Acute Charcot Neuroarthropathy
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Intervention Group, Receiving Medication Subjects in this group will be receiving medication (denosumab) Denosumab: Subjects will receive medication once following enrollment, and will be monitored for 1 year thereafter. 0 None 0 7 2 7 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Muscle pain, upper extremity SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders None View
Cellulitis SYSTEMATIC_ASSESSMENT Infections and infestations None View